Serena Scollen

Serena Scollen has an extensive background in genetic research and project coordination within various prestigious organizations such as GDI, ELIXIR, B1MG Project, FAIRplus, Pfizer, Imperial College London, University of Cambridge, and GlaxoSmithKline. With a PhD in Genetic susceptibility to breast cancer from the University of Cambridge, Serena has held roles such as Head of Human Genomics and Translational Data, Postdoctoral Research Associate, Research Associate, and Molecular Scientist. Serena has a proven track record of leading genetic and precision medicine strategies, managing teams, scoping new technologies, and conducting research in genetic susceptibility to diseases.